Application of 13673-62-6, A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 13673-62-6, Name is 2-(Methylthio)benzo[d]oxazole, molecular formula is C8H7NOS. In a Patent£¬once mentioned of 13673-62-6
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR, AND/OR A BCL-2 INHIBITOR
Therapeutic combinations of a phosphoinositide 3-kinase (PI3K) inhibitor, including PI3K inhibitors selective for the gamma- and delta-isoforms and selective for both gamma- and delta-isoforms (PI3K-gamma,delta, PI3K-gamma, and PI3K-delta), a Janus kinase-2 (JAK-2) inhibitor, a Bruton’s tyrosine kinase (BTK) inhibitor, and/or a B-cell lymphoma-2 (BCL-2) inhibitor are described. In some embodiments, the invention provides therapeutic combinations of a PI3K-delta inhibitor and a BTK inhibitor, a JAK-2 and a BTK inhibitor, and a BCL-2 and BTK inhibitor.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Application of 13673-62-6. In my other articles, you can also check out more blogs about 13673-62-6
Reference£º
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem